Company Overview and News
Stocks are blitzed higher Monday, pushing the Dow Jones Industrial Average back up and over its 50-day moving average, as investors continue to respond to Friday’s “Goldilocks” payroll report.
KEM FR RUN TREX SCHL UNT AVAV AG MRC GBX BEAT
Judging from First Majestic Silver's (AG) stock price, you'd think that silver (SLV) was having an outstanding year. AG stock is up 50% off its lows from earlier in 2018. Actual silver, however, is basically flat, as is gold. Silver and gold currently make up 65% and 24% of the company's revenue profile. Here's how First Majestic stacks up against gold and silver since the beginning of February:
WPM FR PPPMF AG PPP P
TORONTO, ON / ACCESSWIRE / July 2, 2018 / Host Cory Fleck interviews Sandstorm Gold (SSL) (SAND) President and CEO Nolan Watson to discuss the recent Hod Maden Pre-Feasibility Study results as well as the company's strategy to acquire assets with large land packages and significant exploration upside.
FR SAND SSL MUX.RTWI SDDXF AUY MUX YRI SNXZF AG MUX EQXGF
Investors in First Majestic Silver Corp. (AG - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 29, 2018 $6.00 Call had some of the highest implied volatility of all equity options today.
FR EPC AG ZAGG
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Evrim Resources Corp. (TSX-V:EVM) (“Evrim” or the “Company”) is pleased to announce that further to its news release of February 20, 2018, the Company has signed a Definitive Agreement (the “Agreement”) with a subsidiary of Coeur Mining, Inc. (“Coeur”) in respect of the Sarape epithermal gold-silver project in Sonora, Mexico. Coeur will have the exclusive right to acquire up to an 80% interest in Sarape by spending up to US$16.
CDE FR EVM CDEUW AG
NEW YORK, June 15 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX fell 14.54 points, or 0.09 percent, to 16,314.42 but climbed 0.69 percent on the week, its second straight weekly gain. * The biggest contributor to the TSX loss was Toronto-Dominion Bank, pulling 7.6 points from the index. Energy was the heaviest sector drag, with 32.3 net points. * Leading the index were Canada Goose Holdings Inc, up 30 percent in the wake of its quarterly results, Paramount Resources Ltd, up 4 percent, and Prometic Life Sciences Inc, higher by 3.
FR CVE GOOS TNTTF PDS TD TECK CVE BDRPF AG TCKRF POU PFSCF TD PRMRF
Looking back to my silver analysis from early March, silver indeed continued to move sideways for the last three months. The precious metal is still caught in a large consolidation. At least, silver was not much affected by gold's recent plunge below $1,300 USD. Instead prices are barely moving at all.
SVM EXK BLT GLCNF GLNCF TECK FNLPF KGHPF AUCOY AG TCKRF EDR HL.PRB FR SVMLF BHPBF PAAS SVM FSM BHP POYYF BBL HL BHP BHPLF
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up.
HRT MGG HRTFF MMRGF GFI.WI FNV NEM NMKEF RSG PRB RNX RNKLF KGC NMX RMGGF FQVLF AEM MACIF AG FQM GFIOF NDM WPM RPM FR SAND FNV.WT.A SSL GPL SDDXF ALO PROBF K RPMGD WHGOF RPMGF SNXZF ORG RGLD RNX.WT RMGGY GFI PGLC CANWF FNV RGL
First Majestic Silver Corp. (NYSE:AG) has 151 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 69,255,077 shares. Largest shareholders include Wheaton Precious Metals Corp., Van Eck Associates Corp, Morgan Stanley, Vanguard Group Inc, Global X Management CO LLC, Credit Suisse Ag/, Prudential Plc, Connor, Clark & Lunn Investment Management Ltd.
WPM FR MS.PRE MS.PRF MS.PRG MS.PRA PUK.PRA MS.PRI PUK MS.PRK PUK.PR AG MS PUKPF
With continuing downward sentiment in precious metals, it’s important to look at what large traders and hedge funds are doing with their positions in metals. This article focuses on silver, which is predominantly a precious metal and acts as a buffer along with gold during market unrest. Silver was trading at $16.4 per ounce as of 9:00 AM. The resistance level for silver is at a 50-day moving average of $16.
CDE FR PAAS HL CDEUW AG HL.PRB
TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- Discovery Metals Corp. (TSX-V:DSV) ("Discovery" or the "Company") is pleased to announce assay results of 152 samples from its Minerva project ("Minerva" or "the Project"), situated in a northern Coahuila State, Mexico.
FR AYYBF AG
In 2017 and 2018 year-to-date, silver miners considerably underperformed silver. Miners are usually a leveraged play on metals, rising by a higher proportion when metal prices rise and falling harder when metal prices weaken. This trend hasn’t been visible lately as company-specific factors exerted more influence on stock prices.
CDE FR PPPMF PAAS HL CDEUW AG PPP P HL.PRB
VANCOUVER, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- First Majestic Silver Corp. (“First Majestic”) (NYSE:AG) (TSX:FR) (Frankfurt:FMV) is pleased to announce that it has terminated the pre-existing silver purchase agreement with Wheaton Precious Metals Corp. (“WPM”) and its subsidiary, Wheaton Precious Metals International Ltd. (“WPMI”), relating to the newly acquired San Dimas Mine and entered into a new precious metal purchase agreement (the “New Stream Agreement”) with WPMI and FM Metal Trading (Barbados) Inc.
WPM FR AG
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
2018-07-06 - Asif
Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...
Silicon Investor Message Boards
This table lists all message boards related to TSX:FR / First Majestic Silver Co on message board site Silicon Investor.